Low Dose Growth Hormone Treatment in Subjects With Metabolic Syndrome.
NCT00720616
·
clinicaltrials.gov ↗
NA
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Conditions
Metabolic Syndrome
Interventions
DRUG:
Norditropin
Sponsor
Oregon Health and Science University